Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Allogeneic Stem Cell Transplantation (SCT) with Non Myeloablative Conditioning Regimen (NST) Following Intensive Consolidation May Be Equivalent to Conventional alloSCT and Superior to autoSCT for Patients over 50 with Acute Myeloid Leukemia (AML) in 1 st CR: First Results of the AML 2001 Trial.

B. Lioure, J. Delaunay, D. Blaise, N. Milpied, P. Guardiola, J.Y. Cahn, B. Witz, E. Jourdan, L. Legros, E. Randriamalala, M. Ojeda, C. Himberlin, Michel Attal

Blood (2006) 108 (11): 319.

https://doi.org/10.1182/blood.V108.11.319.319

Published: 2006

Journal Articles

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Appropriate for Autologous Stem Cell Transplantation: Results of an Open-Label Phase II Trial.

F. Morschhauser, D. Huglo, G. Martinelli, G. Paganelli, P.L. Zinzani, D. Hadjiyiannakis, A. Liberati, T. Illidge, N. Milpied, H. Stein, J. Kalmus, P. Morel, U. Reimann, R. Marcus

Blood (2004) 104 (11): 130.

https://doi.org/10.1182/blood.V104.11.130.130

Published: 2004

Journal Articles

Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host- graft- versus-leukemia reaction?

G Gallot, MM Hallet, J Gaschet, JF Moreau, R Vivien, M Bonneville, N Milpied, H Vie

Blood (1996) 88 (3): 1098–1103.

https://doi.org/10.1182/blood.V88.3.1098.1098

Published: 1996

Journal Articles

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

Blood (1996) 88 (1): 358–365.

https://doi.org/10.1182/blood.V88.1.358.358

Published: 1996

Journal Articles

High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement [letter]

P Moreau, N Milpied, P de Faucal, T Petit, P Herbouiller, R Bataille, JL Harousseau

Blood (1996) 87 (7): 3063–3064.

https://doi.org/10.1182/blood.V87.7.3063.bloodjournal8773063

Published: 1996

Journal Articles

HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease

J Gaschet, MA Trevino, M Cherel, R Vivien, A Garcia-Sahuquillo, MM Hallet, M Bonneville, JL Harrousseau, R Bragado, N Milpied, H Vie

Blood (1996) 87 (6): 2345–2353.

https://doi.org/10.1182/blood.V87.6.2345.bloodjournal8762345

Published: 1996

Journal Articles

Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]

C Gisselbrecht, D Maraninchi, JL Pico, N Milpied, B Coiffier, M Divine, P Tiberghien, A Bosly, H Tilly, O Boulat

Blood (1994) 83 (8): 2081–2085.

https://doi.org/10.1182/blood.V83.8.2081.2081

Published: 1994

Journal Articles

Double-intensive therapy in high-risk multiple myeloma

JL Harousseau, N Milpied, JP Laporte, P Collombat, T Facon, JD Tigaud, P Casassus, F Guilhot, N Ifrah, C Gandhour

Blood (1992) 79 (11): 2827–2833.

https://doi.org/10.1182/blood.V79.11.2827.2827

Published: 1992

Journal Articles

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

D Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergie, JP Jouet, N Milpied, M Attal, M Michallet, N Ifrah

Blood (1992) 79 (10): 2578–2582.

https://doi.org/10.1182/blood.V79.10.2578.2578

Published: 1992

Journal Articles

Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) [see comments]

P Herve, J Wijdenes, JP Bergerat, P Bordigoni, N Milpied, JY Cahn, C Clement, R Beliard, B Morel-Fourrier, E Racadot

Blood (1990) 75 (4): 1017–1023.

https://doi.org/10.1182/blood.V75.4.1017.1017

Published: 1990

NARROW

Allogeneic Stem Cell Transplantation (SCT) with Non Myeloablative Conditioning Regimen (NST) Following Intensive Consolidation May Be Equivalent to Conventional alloSCT and Superior to autoSCT for Patients over 50 with Acute Myeloid Leukemia (AML) in 1 st CR: First Results of the AML 2001 Trial.

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Appropriate for Autologous Stem Cell Transplantation: Results of an Open-Label Phase II Trial.

Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host- graft- versus-leukemia reaction?

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement [letter]

HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease

Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]

Double-intensive therapy in high-risk multiple myeloma

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) [see comments]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only